SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 194,482.04 |
| Enterprise Value ($M) | 220,622.79 |
| Book Value ($M) | 46,372.00 |
| Book Value / Share | 18.47 |
| Price / Book | 4.14 |
| NCAV ($M) | -31,219.00 |
| NCAV / Share | -12.43 |
| Price / NCAV | -6.15 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.21 |
| Return on Assets (ROA) | 0.16 |
| Return on Equity (ROE) | 0.46 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.16 |
| Current Ratio | 1.41 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 35,503.00 |
| Assets | 115,122.00 |
| Liabilities | 66,722.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 64,168.00 |
| Operating Income | 24,031.00 |
| Net Income | 17,117.00 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 21,468.00 |
| Cash from Investing | -7,734.00 |
| Cash from Financing | -7,032.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 10.02 | 3.47 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 2,652,632 | 10,929,497 | 24.27 | |
| 1,746,549 | 8,478,049 | 20.60 | |
| 2,225,234 | 10,300,992 | 21.60 | |
| 1,895,350 | 9,033,266 | 20.98 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| HYAC – Haymaker Acquisition Corp. 4 | JNJ – Johnson & Johnson |
| LLY – Eli Lilly and Company | NUVB – Nuvation Bio Inc. |
| OGN – Organon & Co. |